Vira Gaevska

Vira Gaevska

Auto-generated profile, based on publicly available information

Vira Gaevska

Medical Clinic MedSpace, Lviv, Ukraine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in Proceeding of the Shevchenko Scientific Society. Medical Sciences
Verified
Journal Article
Open access
PDF file
OBOleksiy Bashkirtsev
Oleksiy Bashkirtsev
VGVira Gaevska
Vira Gaevska
ZBZoriana Bilous
Zoriana Bilous
LLLiliia Lysa
Liliia Lysa
OZOlena Zimba
Olena Zimba
The novel coronavirus disease 2019 (COVID-19) has emerged as a global pandemic that has affected the lives of billions of people. Clinical studies have reported an association between COVID-19 and cardiac diseases. Remote monitoring powered by wearable sensors impacts medical care by enabling health monitoring outside of the clinic. Wearable devices can provide a noninvasive and continuous multi-parameter assessment of ECG, Heart Rate Variability, arterial blood pressure, oxygen saturation and respiratory rate evaluation. Such monitoring may help predict and prevent cardiovascular events related to COVID-19 addresses the growing demand for a novel 5P (Predictive, Preventive, Participatory, Personalized, and Precision) medicine approach. This article aimed to review current and prospective advances in wearable devices for cardiac monitoring and their progress toward clinical application during the COVID-19 pandemic. We performed bibliometric analysis by Scopus, the largest and well organized bibliographic database and analyzed the top-cited articles in this field. Our analysis includes an overview of the most widespread practical implications of CVD-focused remote patient monitoring techniques based on wearable personalized devices. Assessment for both COVID-related conditions and general cases is included in the analysis. Recent studies have reported that cardiac abnormalities present in 19.7-27.8 % of hospitalized patients with COVID-19. COVID-19 associated myocarditis and heart rate abnormalities frequently occur. Additionally, patients with pre-existing CVD and hypertension are at high risk of worse outcomes. Data from several studies have identified atrial fibrillation as the most common form of arrhythmias in COVID-19 patients. Worsening of existing atrial fibrillation in COVID-19 patients is also a serious clinical concern. Implementation of wearable ECG devices for remote monitoring can improve the management of patients with atrial fibrillation and those at high risk for its development. Telecardiology based on wearable devices and remote monitoring allow out-of-hospital control of COVID-19 patients and patients suffering from chronic diseases at high risk of acute cardiovascular events, ensuring their early detection and tracking.

28 December 2022 in Anti-Aging Eastern Europe
Verified
Journal Article
Open access
PDF file
OBOleksii Bashkirtsev
Oleksii Bashkirtsev
VGVira Gaevska
Vira Gaevska
OZOlena Zimba
Olena Zimba
AGArmen Yuri Gasparyan
Armen Yuri Gasparyan
Comprehensive and multidisciplinary rehabilitation is gaining momentum as a useful strategy that aims to improve physical, psychological, and social components of health in subjects affected by violence, trauma, and mental distress. Previous and current wars have prioritized essential diagnostic and rehabilitative services to civil subjects and military servicepersons which can be delivered by skilled physiatrists and allied specialists. Stratifying subjects in need of various rehabilitative procedures and offering them psychological support, balanced nutrition, musculoskeletal care, and socialisation in a safe and relaxing atmosphere may improve their mental and functional capacities and resolve numerous health issues. The choice of comprehensive rehabilitative procedures depends on their availability and understanding of complementary effects of various interventions.

29 December 2021 in Proceeding of the Shevchenko Scientific Society. Medical Sciences
Verified
Journal Article
Open access
PDF file
OBOleksiy Bashkirtsev
Oleksiy Bashkirtsev
VSVitaliy Sagan
Vitaliy Sagan
VGVira Gaevska
Vira Gaevska
OZOlena Zimba
Olena Zimba
Introduction. Biomarkers of biological age (BA) are essential for anti-aging research and practice because of their prediction of life expectancy, detection of premature aging, and estimation of anti-ageing programs' effectiveness. The purpose of this study is a clinical validation of the method of biological age estimation based on the analysis of heart rate variability (HRV), artificial intelligence technologies, and biometric monitoring. Methods. In 51 patients who received wellness and rehabilitation services in the medical center "Edem Medical", biological age was determined based on the analysis of HRV and machine learning algorithms. A comparison was made between the proposed method and other known methods of biological age estimation. Biological age estimation by physicians which is based on the Frailty Index was chosen as a reference method. The second method was DNA methylation age (DNAm PhenoAge). This method predicts biological age based on nine parameters of blood (albumin, creatinine, glucose, C-reactive protein, lymphocytes [%], mean corpuscular volume [MCV], red cell distribution width [RDW], alkaline phosphatase, WBC count). Using the «leave one out» technique, an additional algorithm was created for approximating biological age in view of blood test parameters and ECG signals as input data. Morning HRV assessment was performed on empty stomach and after 10-minute rest in horizontal position. ECG was recorded using Mawi Vital multisensor device. The following statistical tests were used to reveal associations between different methods of biological age estimation: 1. bivariate correlation, 2. mean absolute error (MAE), 3. qualitative binary age estimation. Results. All tested methods of BA evaluation were strongly correlated with the reference method (physician-determined age). HRV based approach was superior in comparison with other methods. In 9 out of 10 cases, the qualitative binary age assessment using HRV coincided with the reference method. The HRV method was the most accurate for biological age estimation (3.62 vs 12.62) based on MAE. Conclusion. The method based on HRV is an affordable and convenient approach to biological age estimation. This method offers opportunities for early stratification of individuals at risk of accelerated aging. It combines well with the paradigm of 3 P medicine which is based on Prevention, Prediction, and Personalized approach to each patient

20 June 2025 in Proceeding of the Shevchenko Scientific Society. Medical Sciences
Verified
Journal Article
Open access
PDF file
IHIhor Hayduchok
Ihor Hayduchok
YFYuryі Fedorov
Yuryі Fedorov
TPTetyana Pastryk
Tetyana Pastryk
OSOksana Souter
Oksana Souter
VGVira Gaevska
Vira Gaevska
AKAlona Kovpak
Alona Kovpak
Introduction. Today, arterial hypertension (AH) is the most common cardiovascular disease, posing a significant risk of disability due to complications such as heart failure, ischaemic heart disease and stroke. This study examines the effect of quercetin, the active ingredient in Corvitin, which is a member of the group of natural flavonoids with antioxidant, anti-inflammatory and cardioprotective properties. The combined effect of Corvitin in combination with antihypertensive drugs in the treatment of arterial hypertension has not been thoroughly studied, which highlights the relevance and purpose of our study. The aim of the study is to determine the potential benefits of the combined use of corvitin with antihypertensive drugs to improve the state of prooxidant-antioxidant balance in hypertension. Materials and methods. The study was conducted in spontaneously hypertensive rats (SHR). Animals were divided into 12 observation groups. The experimental groups received ramipril (5 mg/kg), candesartan (4 mg/kg), corvitin (50 mg/kg), or a combination of ramipril and corvitin or candesartan and corvitin. The drugs were taken for seven days. The prooxidant-antioxidant status in the heart, liver, and kidneys was assessed by measuring the levels of malondialdehyde (MDA) and diene conjugate (DC), along with the activity of antioxidant enzymes: superoxide dismutase (SOD), glutathione peroxidase (GPО), and catalase (CAT). Results of the study. Monotherapy with ramipril exacerbated pathological processes in the kidneys, heart and liver, which led to a decrease in the level of antioxidant defence enzymes. While the levels of malondialdehyde and diene conjugate remained unchanged, candesartan treatment showed a more favourable trend towards a decrease in peroxidation products, superoxide dismutase activation, a slight increase in catalase levels, and unchanged glutathione peroxidase activity. Combined therapy with corvitin significantly shifted the prooxidant-antioxidant balance towards an increase in the activity of catalase and superoxide dismutase enzymes, while significantly reducing the levels of barbituric acid products. The most pronounced positive changes were observed in the left ventricular myocardium and kidneys when corvitin was administered with candesartan. Conclusions. The combined use of corvitin and antihypertensive drugs has been shown to be beneficial for the overall pro-oxidant antioxidant system. This positive synergy not only reduces blood pressure, but also enhances the pleiotropic effects of corvitin.